12% of adults had used a GLP-1 prescription drug as of May 2024, and global spending is expected to multiply from $6 billion in 2023 to $105 billion by 2030
Why Professional Supervision Matters The peptide world is filled with conflicting information, inconsistent dosing advice, and heavily marketed products with little oversight
Can GHK-Cu replace finasteride or minoxidil
Further studies are needed to investigate this hypothesis, but we suspect recent changes in medication prescribing practices and medication prices will result in large datasets allowing scientists to investigate these potential relationships. Christine Rode Schwarz, PhD, of the Steno Diabetes Center in Copenhagen, and her co-authors pointed to this case in a commentary titled, Mechanism and Context: Making Sense of Adverse Events With GLP-1-based Therapy , also published in JCEM Case Reports later that year
Breast cancer survivors may also be taking other medicines, including hormonal therapies, which could potentially interact with metabolic treatments
